RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
14.25
+1.06 (8.04%)
At close: Jan 27, 2023, 4:00 PM
14.96
+0.71 (4.98%)
After-hours: Jan 27, 2023, 7:11 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Revenue
22.5914.682.24
Revenue Growth (YoY)
53.92%554.98%-
Cost of Revenue
18.0812.974.06
Gross Profit
4.521.71-1.82
Selling, General & Admin
32.8115.1815.2
Research & Development
24.521.9329.57
Other Operating Expenses
00.01-0.52
Operating Expenses
57.337.1244.25
Operating Income
-52.79-35.41-46.07
Interest Expense / Income
3.680.510.03
Other Expense / Income
-7.79-63.55-172.34
Pretax Income
-48.6827.63126.24
Income Tax
0.010.060.02
Net Income
-48.6927.58126.22
Preferred Dividends
024.21100.09
Net Income Common
-48.693.3726.13
Net Income Growth
--87.12%-
Shares Outstanding (Basic)
144-
Shares Outstanding (Diluted)
146-
Shares Change
146.28%--
EPS (Basic)
-3.570.91-
EPS (Diluted)
-3.570.15-
Free Cash Flow Per Share
-3.42-10.18-
Gross Margin
19.99%11.62%-81.17%
Operating Margin
-233.64%-241.26%-2055.78%
Profit Margin
-215.50%22.93%1165.86%
Free Cash Flow Margin
-206.47%-257.11%-1967.96%
Effective Tax Rate
-0.21%0.02%
EBITDA
-41.0132.15130.2
EBITDA Margin
-181.52%219.06%5809.91%
Depreciation & Amortization
3.994.013.93
EBIT
-4528.14126.27
EBIT Margin
-199.17%191.73%5634.54%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).